Breckwoldt Michael O, Bode Julia, Kurz Felix T, Hoffmann Angelika, Ochs Katharina, Ott Martina, Deumelandt Katrin, Krüwel Thomas, Schwarz Daniel, Fischer Manuel, Helluy Xavier, Milford David, Kirschbaum Klara, Solecki Gergely, Chiblak Sara, Abdollahi Amir, Winkler Frank, Wick Wolfgang, Platten Michael, Heiland Sabine, Bendszus Martin, Tews Björn
Neuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
Elife. 2016 Feb 2;5:e11712. doi: 10.7554/eLife.11712.
Neoangiogenesis is a pivotal therapeutic target in glioblastoma. Tumor monitoring requires imaging methods to assess treatment effects and disease progression. Until now mapping of the tumor vasculature has been difficult. We have developed a combined magnetic resonance and optical toolkit to study neoangiogenesis in glioma models. We use in vivo magnetic resonance imaging (MRI) and correlative ultramicroscopy (UM) of ex vivo cleared whole brains to track neovascularization. T2* imaging allows the identification of single vessels in glioma development and the quantification of neovessels over time. Pharmacological VEGF inhibition leads to partial vascular normalization with decreased vessel caliber, density, and permeability. To further resolve the tumor microvasculature, we performed correlated UM of fluorescently labeled microvessels in cleared brains. UM resolved typical features of neoangiogenesis and tumor cell invasion with a spatial resolution of ~5 µm. MR-UM can be used as a platform for three-dimensional mapping and high-resolution quantification of tumor angiogenesis.
新生血管生成是胶质母细胞瘤的一个关键治疗靶点。肿瘤监测需要成像方法来评估治疗效果和疾病进展。到目前为止,肿瘤脉管系统的测绘一直很困难。我们开发了一种结合磁共振和光学的工具包来研究胶质瘤模型中的新生血管生成。我们使用体内磁共振成像(MRI)和对离体清除全脑的相关超微显微镜(UM)来追踪新血管形成。T2*成像可在胶质瘤发展过程中识别单个血管,并随时间对新血管进行定量。药理学上的血管内皮生长因子(VEGF)抑制导致血管部分正常化,血管口径、密度和通透性降低。为了进一步解析肿瘤微血管系统,我们对清除脑内荧光标记的微血管进行了相关超微显微镜检查。超微显微镜以约5微米的空间分辨率解析了新生血管生成和肿瘤细胞侵袭的典型特征。磁共振-超微显微镜可作为肿瘤血管生成三维测绘和高分辨率定量的平台。